Neurological Disease News and Research

RSS

FUSCLEAN technology enables preventive cleaning of catheters and valves in patients with hydrocephaly

Researchers at the University of Seville and University Hospital Virgen del Rocío have published the results of the first successful test of a new technology created to prevent obstructions in catheters and valves (shunts) implanted in the brain of patients with hydrocephalus.

12 Oct 2022

UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseases

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain diseases and disorders of the central nervous system.

26 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.

From AbbVie 8 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

Researchers identify potential new pathway for treating a sporadic form of ALS

Researchers have published two papers describing how they identified a potential new pathway for treating a sporadic form of amyotrophic lateral sclerosis (ALS).

30 Aug 2022

AI can detect Parkinson’s from nighttime breathing patterns

Researchers develop an artificial intelligence-based model to detect Parkinson’s disease and track its progression from nocturnal breathing signals.

25 Aug 2022

Combination of new testing methods helps identify multiple dementia risk genes

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.

18 Aug 2022

What are the risk factors related to COVID-19-related hospitalization and mortality?

In a new study, researchers assessed the risk factors associated with COVID-19-related hospitalization or mortality.

16 Aug 2022

Blood-based biomarkers can accurately predict a patient's risk of death or disability after TBI

A study funded by the National Institutes of Health found that biomarkers present in the blood on the day of a traumatic brain injury (TBI) can accurately predict a patient's risk of death or severe disability six months later.

10 Aug 2022

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

In this interview, we speak to Tom Kostrzewski, VP of Science and Technology at CN Bio, about their organ-on-a-chip product and the future of drug discovery.

From CN-Bio 3 Aug 2022

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder.

2 Aug 2022

Researchers characterize a novel gene likely to cause neurological disorders in humans

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/MedUni Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as autism, ADHD, schizophrenia, and neurodegenerative disorders including Alzheimer's. The study makes an important contribution to the understanding of the extracellular matrix in the brain and its associated neurological diseases.

2 Aug 2022

Neurological Disease News and Research

FUSCLEAN technology enables preventive cleaning of catheters and valves in patients with hydrocephaly

UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseases

Designing a new treatment to treat migraine effectively

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

Neurological manifestations associated with monkeypox infection

Researchers identify potential new pathway for treating a sporadic form of ALS

AI can detect Parkinson’s from nighttime breathing patterns

Combination of new testing methods helps identify multiple dementia risk genes

What are the risk factors related to COVID-19-related hospitalization and mortality?

Blood-based biomarkers can accurately predict a patient's risk of death or disability after TBI

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

Researchers characterize a novel gene likely to cause neurological disorders in humans

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

How COVID-19 affects the brain microvasculature

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Immune response triggered by COVID-19 damages the brain's blood vessels to cause neurological complications

Elevated cerebrospinal fluid biomarkers of neuroinflammation in NeuroCOVID patients

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

Neuroscience - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News